Brief: Mymd Pharmaceuticals Subsidiary Oravax Medical Preparing To Commence Clinical Trials For Oral Covid-19 Vaccine

Q/C Technologies

10/08/2021 18:10

Aug 10 (Reuters) - MyMD Pharmaceuticals Inc  MYMD.O :
    * MYMD PHARMACEUTICALS SUBSIDIARY ORAVAX MEDICAL PREPARING
TO
COMMENCE CLINICAL TRIALS FOR ORAL COVID-19 VACCINE

Source text for Eikon:  ID:nBw6XDMHLa 
Further company coverage:  MYMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))